Our Australian Natural range is grown and manufactured in Australia. Our Global Selects range is grown by our global partners to GACP standards and manufactured in our Australian GMP facilities.
We are continually investing in cutting edge research and evidence-based practice.
For details regarding our current research projects please visit our research page.
Find out how plant-based medicines can play a role in the holistic treatment of your patient, and the regulatory pathways required to become a prescriber.
SAS-B is an application pathway that can be accessed by health practitioners. The application is approved on a case-by-case basis and requires a clinical justification for the use of the product including why plant-based medicine is preferred compared to other approved medicines and an appraisal of the expected clinical benefits verse the potential risks. An application can be submitted to the TGA via the SAS and Authorised Prescriber Online System.
An Authorised Prescriber can supply plant-based treatments directly to specified patients under their immediate care without requiring separate approval for individual patients.
The standard pathway requires a 2-step application process:
1. Submit an application to a Human Rights Ethics Committee (HREC) or a specialist college and receive approval
2. Complete an online application to the TGA using the SAS and Authorised Prescriber Online System
|Key features||Authorised Prescriber||SAS-B|
|Medical practitioners can apply||Yes||Yes|
|Other health practitioners can apply||No||Yes|
|Requires submission to TGA for every patient||No||Yes|
|Requires six monthly patient number reporting||Yes||No|